Pharmaceutical Compositions Comprising Nilotinib or Its Salt

A pharmaceutical composition, especially capsules, comprising granules containing nilotinib or a salt thereof with at least one pharmaceutically acceptable excipient. The granules may be produced by a wet granulation process.

Pharmaceutical compositions comprising nilotinib or its salt

MEDICAL OR VETERINARY SCIENCE; HYGIENE

Medicinal preparations characterised by special physical form -Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles -Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction -Excipients; Inactive ingredients-Organic compounds, e.g. phospholipids, fats

PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 

Medicinal preparations containing organic active ingredients-Heterocyclic compounds-having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins-having six-membered rings with two ; or more;  nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines-Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim-not condensed and containing further heterocyclic rings

Antineoplastic agents-specific for leukemia

SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Antineoplastic agents

Medicinal preparations characterised by special physical form -Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles -Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction -Excipients; Inactive ingredients-Organic macromolecular compounds-obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Medicinal preparations characterised by special physical form -Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles -Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction -Excipients; Inactive ingredients-Organic macromolecular compounds-obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Medicinal preparations characterised by special physical form -Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles -Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction -Excipients; Inactive ingredients-Organic compounds, e.g. phospholipids, fats-Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Invalidity analysis

Prosecution analysis

Examiner search

General

Analytics

Cases

Patent Assignments

Citations